Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
Yijia Li(Brigham and Women's Hospital), Jonathan Z. Li(Brigham and Women's Hospital), James Regan(Brigham and Women's Hospital), Alexandra Rosenthal(Brigham and Women's Hospital), Kendyll Coxen(Brigham and Women's Hospital), Jesse Fajnzylber(Brigham and Women's Hospital), Caroline Atyeo(Ragon Institute of MGH, MIT and Harvard), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Stephanie Fischinger(Leiden University), Xu G. Yu(Massachusetts General Hospital), Arthur Kim(Harvard University), Colline Wong(Brigham and Women's Hospital), Lindsey R. Baden(Brigham and Women's Hospital), Elizabeth Gillespie(University of Colorado Hospital), Rida Chishti(Brigham and Women's Hospital), Heather Corry(Brigham and Women's Hospital)
Cited by 65
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis
|Clinical Infectious Diseases|2001|969